Heredia, Costa Rica – Nuproxa, a leading company in natural solutions for the animal health and nutrition industry, was present at the XXVI Central American and Caribbean Poultry Congress. The event was held from June 21 to 23 in the city of Heredia, Costa Rica. During the congress, Nuproxa was located at booth number 115 of its regional affiliate and local distributor, Cartasa, where it presented its innovative natural solutions for poultry feed. 

One of the outstanding products on display was BioCholine, recognized for its efficiency and cost-effectiveness in the metabolic modulation of poultry. Visitors to the congress had the opportunity to learn more about the advantages and benefits of this product, which contributes to improve the performance and health of poultry in a natural way. 

In addition to its participation in the booth, Nuproxa gave a presentation during the congress. The Vice President of Business Latam of Nuproxa Switzerland, Homero Borin, was in charge of presenting the topic “Natural alternatives to additives in animal nutrition and health”. The presentation took place on Thursday, June 22, at 3:45 pm Costa Rican time, in the Tamarindo room. 

“Nuproxa’s presence at the Central American and Caribbean Poultry Congress 2023 reaffirmed our commitment to the region’s poultry industry and our continuous search for natural solutions,” said company CEO Mathias Huber, adding “We are honored to contribute to the development and growth of this vital sector for the regional economy.” 

For more information about Nuproxa’s products and services, please contact us through our website: www.nuproxa-cac.com. 

About Nuproxa Switzerland

Founded in 2007, Nuproxa is a company specialized in natural solutions for the animal health and nutrition industry. Its mission is to offer high quality products with high profitability and safety. The company is FAMI-QS certified and its products have proven efficacy for animal health and welfare, with tests conducted in the world’s most renowned research institutes and universities and results demonstrated in real experimental and commercial conditions. Present in more than 25 countries in Latin America and Europe, Nuproxa has been growing at an average rate of 20% per year, as a result of the company’s strong commitment to its business partners, to the R&D of its products and mainly to its customers.   

www.nuproxa.ch

www.nuproxa-cac.com